Abstract

NENINGER VINAGERAS, Elia et al. Treatment of small cell lung carcinoma. Rev cubana med [online]. 2008, vol.47, n.4, pp. 0-0. ISSN 1561-302X.

The results of a retrospective study of patients with small cell lung carcinoma in all the stages of the disease diagnosed by cytology and/or biopsy of the lesion were reported. Methods: 68 patients that suffered from a small cell lung carcinoma in all the stages that received first-line treatment with cisplatin-etoposide, and second line treatment with cyclophosphamide, doxorubicin and vincristine were studied. The patients with limited disease were evaluated at the end of the first cycle to plan the treatment with radiations; those with extended disease received radiations on metastic sites or to improve some symptom. Results: The response to the treatment was as follows: 25 % of objective response (CR and PR) and 56 % of control of the disease. The global mean survival was 10.10 months. Among females, it was observed a trend towards an increase of survival compared with males (10.23 vs. 9.33 months). The survival of the limited disease was 12.5 months, whereas in the extended disease it was 6.57 months, which was statistically significant (p = 0,004).

Keywords : Small cell carcinoma.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )